NDC 62207-827 – Guaifenesin and Pseudoephedrine HCl

Guaifenesin 600 mg/1; Pseudoephedrine Hydrochloride 60 mg/1 · Tablet, Extended Release · Oral

Human Otc Drug

Product NDC62207-827

Product details

Brand name
Guaifenesin and Pseudoephedrine HCl
Generic name
Guaifenesin and Pseudoephedrine HCl
Labeler
Granules India Ltd
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA216082
Marketed since
June 1, 2023
Listing expires
December 31, 2026
Pharmacologic class
Expectorant; alpha-Adrenergic Agonist

Active ingredients

Uses, dosage, side effects and warnings for Guaifenesin and Pseudoephedrine HCl →

Package NDC codes (1)

Package NDCDescriptionSince
62207-827-729 BLISTER PACK in 1 CARTON (62207-827-72) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACKJun 1, 2023

Other Guaifenesin and Pseudoephedrine HCl products